Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation

Journal of Veterinary Emergency and Critical Care

Volumn 21, Issue 6, 2011, Pages 666-672

  Wright, Heather M ^a   Chen, Annie V ^a   Talcott, Patricia A ^a   Poppenga, Robert H ^b   Mealey, Katrina L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system depressants; Neurotoxicity; P glycoprotein

Indexed keywords

CANIS FAMILIARIS;

GLYCOPROTEIN P; IVERMECTIN; LIPID EMULSION;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; FEMALE; GENETICS; MALE; MUTATION; TOXICITY AND INTOXICATION; TREATMENT FAILURE;

ANIMALS; DOG DISEASES; DOGS; FAT EMULSIONS, INTRAVENOUS; FEMALE; IVERMECTIN; MALE; MUTATION; NEUROTOXICITY SYNDROMES; P-GLYCOPROTEIN; TREATMENT FAILURE;

EID: 84861428751     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2011.00687.x     Document Type: Article

References (26)

1. Hopper K, Aldrick J, Haskins SC. Ivermectin toxicity in 17 collies. J Vet Intern Med 2002; 16:89-94.
2. Lovell RA. Ivermectin and piperazine toxicoses in dogs and cats. Vet Clin North Am: Small Anim Pract 1990; 20:453-468.
3. Mealey KL, Bentjen SA, Gay JM, et al. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001; 11:727-733.
4. Merola V, Khan S, Gwaltney-Brant S. Ivermectin toxicosis in dogs: a retrospective study. J Am Anim Hosp Assoc 2009; 45:106-111.
5. Tranquilli WJ, Paul AJ, Seward RL, et al. Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis. J Vet Pharmacol Ther 1987; 10:96-100.
6. Muhammad G, Jabbar A, Khan MZ, et al. Use of neostigmine in massive ivermectin toxicity in cats. Vet Hum Toxicol 2004; 46:28-29.
7. Sivine F, Plume C. Ansay M. Picrotoxin, the antidote to ivermectin in dogs? Vet Rec 1985; 116:195-196.
8. Muller JMV, Feige K, Kastner SBR, et al. The use of sarmazenil in the treatment of a moxidectin intoxication in a foal. J Vet Intern Med 2005; 19:348-349.
9. Jamaty C, Bailey B, Larocque A, et al. Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol 2010; 48:1-27.
10. Weinberg G, Ripper R, Feinstein DL, et al. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med 2003; 28:198-202.
11. Weinberg GL, VadeBoncouer T, Ramaraju GA, et al. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 1998; 88:1071-1075.
12. Harvey M, Cave G, Hoggett K. Correlation of plasma and peritoneal diasylate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits. Acad Emerg Med 2009; 16:151-156.
13. Mazoit JX, Guen RL, Beloeil H, et al. Binding of long-lasting local anesthetics to lipid emulsions. Anesthesiology 2009; 110:380-386.
14. Zausig YA, Zink W, Keil M, et al. Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest but not from ropivacaine- or mepivacaine-induced cardiac arrest. Anesth Analg 2009; 109:1323-1326.
15. Bania TC, Chu J, Perez E, et al. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med 2007; 14:105-111.
16. Cave G, Harvey M, Castle C. Intralipid ameliorates thiopentone induced respiratory depression in rats: investigative pilot study [letter]. Emerg Med Australas 2005; 17:180-181.
17. Lespine A, Dupuy J, Alvinerie M, et al. Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs. Curr Drug Metab 2009; 10:272-288.
18. Crandell DE, Weinberg GL. Moxidectin toxicosis in a puppy successfully treated with intervenous lipids. J Vet Emerg Crit Care 2009; 19:181-186.
19. Pritchard J. Treating ivermectin toxicity in cats. Vet Rec 2010; 166:766.
20. Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med 2009; 16:815-824.
21. Geyer J, Gavrilova O, Petzinger E. Brain penetration of ivermectin and selamectin in mdr1a, b P-glycoprotein- and bcrp-deficient knockout mice. J Vet Pharmacol Ther 2008; 32:87-96.
22. Pulliam JD, Seward RL, Henry RT, et al. Investigating ivermectin toxicity in collies. Vet Med 1985; 80:33-40.
23. Mealey KL. Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 2004; 27:257-264.
24. Coelho JC, Tucker R, Mattoon J, et al. Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Δ mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency. J Vet Pharmacol Ther 2009; 32:417-421.
25. Tranquilli WJ, Paul AJ, Seward RL. Ivermectin plasma concentration in Collies sensitive to ivermectin-induced toxicosis. Am J Vet Res 1989; 50:769-770.
26. Trailovic SM, Nedeljkovic JT. Central and peripheral neurotoxic effects of ivermectin in rats. J Vet Med Sci 2010 Available at: Accessed Apr 6, 2011.